Xin Zhang1,2, Shan Lu3, Li Wang4, Shumei Miao1,2, Yuechuchu Yin1,2, Shengqi Jing1,2, Tao Shan1,2, Xiaoliang Zhang1,2, Zuolei Dai1,2, Zhongmin Wang1,2 and Yun Liu1,2,3*
1Department of Information, Nanjing Medical University, China
2School of Biomedical Engineering and Informatics, Nanjing Medical University, China
3Department of Health Education, Nanjing Medical University, China
4Department of Medical Informatics, Nantong University, China
This paper cleaned, transformed and imported EMR data into OMOP CDM using distributed network and Observational Health Data Sciences and Informatics (OHDSI) tools. The treatment pathways were analyzed retrospectively, and the effects of the four medications most commonly used in the second-line therapy after the first-line of metformin recommended by the guidelines were compared emphatically. The conclusion would be one of the bases for the selection of clinical treatment in the future.
Zhang X, Lu S, Wang L, Miao S, Yin Y, Jing S, et al. An Effective Treatment Pathways Study for Type-2 Diabetes. Clin Surg. 2019; 4: 2497.